Clinical Trial Update: Re-entry XR-NTX for Rural Individuals With Opioid Use Disorder [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 early trial update for re-entry XR-NTX in rural individuals with opioid use disorder has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• XR-NTX (naltrexone extended-release injectable)

Snippet

Sponsor: Michele Staton | Conditions: Opioid Dependence | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2023-03-27